Research Article

[Retracted] Effectiveness of GnRH Antagonists and Agonists in Patients with Hormone-Sensitive Prostate Cancer: A Retrospective Study

Table 2

Baseline data of the included patients after propensity score matching.

IndicatorsAntagonistAgonist value

Cases ()3232
Age (year)0.883
TNM stage ()0.617
 T1-T222
 T3-T477
 M12323
Gleason score0.651
 ≤7 points89
 >7 points2423
PSA control rate (%)0.044
With abiraterone84.3853.13
Without abiraterone66.6750
Median value of PSA baseline level (ng/ml)204.85211.820.864
Median time to reexamination (day)60630.861